The amount of improvement of a genetic disease is measured for 18 patients who are randomly assigned to the nine experimental configurations, with two patients to each configuration, corresponding to three dosage levels of each of two active ingredients of a drug. The experimental results are given in DS 14.1.4. Analyze this data set. What do you notice when you plot the residuals against the levels of ingredient B?